← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2008First marketed drug
Jun 14, 1930First NDA
Oct 5, 1994Last known activity
Mar 30, 2017
Acquired by Stallergenes on Jun 1, 2015
Timeline
1900s
- Jul 1, 1904
Greer Laboratories— Founded
1950s
- Sep 15, 1958
house dust mite allergen— NDA Secondary Org
1990s
- Oct 5, 1994
plague vaccine— NDA Organization
2010s
- Jun 1, 2015
Stallergenes— Acquired By
Drugs by trial phase (3 distinct, 4 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Marketed drugs (12)
- orchard grass pollen allergen
- timothy grass pollen allergen extract
- house dust mite allergen
- short ragweed pollen allergen
- plague vaccine
- cat epidermis allergen
- redtop grass pollen allergen
- bermuda grass pollen allergen
- kentucky bluegrass pollen allergen
- meadow fescue grass pollen allergen
- sweet vernal grass pollen allergen
- lolium perenne pollen
Recent trials (5)
- NCT03038971Lead sponsorPhase 1Mar 30, 2017
- NCT01353079Lead sponsorPhase 3Apr 1, 2011
- NCT00732654CollaboratorPhase 1/Phase 2Aug 1, 2008
- NCT00599872Lead sponsorPhase 3Mar 1, 2008
- NCT00599872Study directorPhase 3Mar 1, 2008
Details
- Founded
- Lenoir, NC, US Jul 1, 1904
- First NDA
- Oct 5, 1994
- Last known activity
- Mar 30, 2017
Notes
acquired by Stallergenes 2 Oct 2017